| EASL Clinical Practice Guidelines: management of hepatitis C virus infection European Association For The Study Of The Liver Journal of hepatology 55 (2), 245-264, 2011 | 2282 | 2011 |
| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 1892 | 2017 |
| Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ... The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018 | 1254 | 2018 |
| Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis GP Aithal, JA Thomas, PV Kaye, A Lawson, SD Ryder, I Spendlove, ... Gastroenterology 135 (4), 1176-1184, 2008 | 821 | 2008 |
| Prednisolone or pentoxifylline for alcoholic hepatitis MR Thursz, P Richardson, M Allison, A Austin, M Bowers, CP Day, ... New England Journal of Medicine 372 (17), 1619-1628, 2015 | 711 | 2015 |
| Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol … R Williams, R Aspinall, M Bellis, G Camps-Walsh, M Cramp, A Dhawan, ... The Lancet 384 (9958), 1953-1997, 2014 | 622 | 2014 |
| Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults SD Ryder Gut 52 (suppl 3), iii1-iii8, 2003 | 602 | 2003 |
| The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ... Journal of viral hepatitis 21, 34-59, 2014 | 537 | 2014 |
| Mannose binding protein gene mutations associated with unusual and severe infections in adults JA Summerfield, S Ryder, M Sumiya, M Thursz, A Gorchein, MA Monteil, ... The Lancet 345 (8954), 886-889, 1995 | 455 | 1995 |
| Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology MM Skelly, PD James, SD Ryder Journal of hepatology 35 (2), 195-199, 2001 | 422 | 2001 |
| Historical epidemiology of hepatitis C virus (HCV) in selected countries P Bruggmann, T Berg, ALH Øvrehus, C Moreno, CE Brandão Mello, ... Journal of viral hepatitis 21, 5-33, 2014 | 393 | 2014 |
| Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study SD Ryder Gut 53 (3), 451-455, 2004 | 381 | 2004 |
| The UK‐PBC risk scores: derivation and validation of a scoring system for long‐term prediction of end‐stage liver disease in primary biliary cholangitis M Carbone, SJ Sharp, S Flack, D Paximadas, K Spiess, C Adgey, ... Hepatology 63 (3), 930-950, 2016 | 333 | 2016 |
| Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study H Razavi, S Robbins, S Zeuzem, F Negro, M Buti, AS Duberg, ... The lancet Gastroenterology & hepatology 2 (5), 325-336, 2017 | 271 | 2017 |
| International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways HJ Cordell, Y Han, GF Mells, Y Li, GM Hirschfield, CS Greene, G Xie, ... Nature communications 6 (1), 8019, 2015 | 270 | 2015 |
| Strategies to manage hepatitis C virus (HCV) disease burden H Wedemeyer, AS Duberg, M Buti, WM Rosenberg, S Frankova, G Esmat, ... Journal of viral hepatitis 21, 60-89, 2014 | 268 | 2014 |
| Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis. G Rogers, P Hewson, D Wright, R Anderson, M Cramp, S Jackson, ... Health technology assessment (Winchester, England) 11 (34), 1-206, 2007 | 259 | 2007 |
| Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine PD Richardson, PD James, SD Ryder Journal of hepatology 33 (3), 371-375, 2000 | 255 | 2000 |
| The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology J Trebicka, J Fernandez, M Papp, P Caraceni, W Laleman, C Gambino, ... Journal of hepatology 73 (4), 842-854, 2020 | 222 | 2020 |
| Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection K Agarwal, SK Fung, TT Nguyen, W Cheng, E Sicard, SD Ryder, ... Journal of hepatology 62 (3), 533-540, 2015 | 205 | 2015 |
